We have a vast network of Israeli and American investors, entrepreneurs, and like-minded visionaries who want to help craft the future of the cannabis industry
Ari Cohen joined Dixie Brands, Inc. in March 2017 as the Director of National Operations. In this role, he oversees global manufacturing, product innovation, compliance and organizational scaling. Ari is Co-Founder and Board Member of HeyMary, an AI driven diagnosing, dosing and dispensing device.
Prior to joining Dixie, Ari was a consultant focused on growing brands, recipe innovation, production efficiency, and quality assurance. He has extensive franchise experience garnered from his time with Le Pain Quotidien, where as Corporate Chef he grew the company from eight locations to over 200 worldwide. Prior to Le Pain, Mr. Cohen held a leadership role at Danny Meyer’s Union Square Café and worked with Max Brenner and Magnolia Bakery among other global brands.
Jeffrey Samuels is an active entrepreneur, investor, and proud community member in the cannabis industry. Currently, he is the VP of Business Development & Founding member at HillviewMed, a New Jersey based vertically integrated cannabis company launched in 2018. Jeffrey is also a Principal at Q56 Capital, an early stage investment and advisory firm focused on cannabis, real-estate, and technology. Prior to HillviewMed, he was founding member of AlphaRoot, a first of it's kind insurance and technology platform for the cannabis industry. Jeffrey was named to the National Cannabis Industry Association's Finance and Insurance Committee (NCIA) in it's inaugural year, where he still plays an active role and maintains his insurance licenses as a Commercial Lines Coverage specialist (CLCS).
David Wenger is a New York City attorney and a specialist in the US cannabis industry. He focuses on the policy developments, reforming laws, evolving politics, dynamic economies, and medical discoveries transforming the US cannabis industry. David advises business entrants and institutional, family office, and HNW investors on opportunities in the industry.
David wrote the seminal White Paper on the US cannabis industry, “The Green Regulatory Arbitrage: A Case for Investing in US Multi-State Vertically-Integrated Cannabis Companies,” published on New Cannabis Ventures. He has been invited to discuss the industry at events in the US and abroad for finance and medical professionals.
Adam has worked within the Australian startup ecosystem for almost a decade. In 2015, Adam became involved in the medical cannabis space due to his passion for the medicine and belief in innovation stimulating its growth. In 2016, Adam founded BuddingTech, Australia’s first medical cannabis startup incubation program. Additionally, Adam also founded the Medical Cannabis Council, Australia's first national industry body to represent the medical cannabis industry in Australia. Adam has spoken at several international events and sits on the advisory board of several cannabis companies.
David J. Casarett, MD, MA
Dr. Casarett’s major research interest is understanding and improving the way that health systems care for patients near the end of life. His work has included studies of hospice and hospice alternatives, as well as a randomized controlled trial of a decision aid to improve end of life care. Dr. Casarett is also a recipient of the Presidential Early Career Award for Scientists and Engineers, the highest honor given by the US government to researchers in the early stages of their careers.
Moshe Feiglin is the Founder and Chairman of the Zehut (Jewish Identity) Party which seeks to lead Israel based on the concepts of identity, meaning and liberty. He is a former Member of Knesset and served as the Deputy Speaker of the Knesset from 2013-2015.
During his term in the Knesset, Feiglin championed the call for increased legalization and use of medical cannabis. He has lectured on this topic quite extensively and has written about it in many forums. Feiglin has debated this issue with many cannabis opponents and is the #1 voice in Israel today on this issue.